ArticleJournal of experimental & clinical cancer research : CR2025

Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.

Ella A Eklund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.